334 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
ACN Accenture plc $171.04 $109.71B N/A
Article Searches
Accenture (ACN) Tops Q2 Earnings and Revenue Estimates http://www.zacks.com/stock/news/366272/accenture-acn-tops-q2-earnings-and-revenue-estimates?cid=CS-ZC-FT-366272 Mar 28, 2019 - Accenture (ACN) delivered earnings and revenue surprises of 10.19% and 1.63%, respectively, for the quarter ended February 2019. Do the numbers hold clues to what lies ahead for the stock?
Democratizing Blockchain Beyond Bitcoin: Tech Giants to Gain http://www.zacks.com/stock/news/365533/democratizing-blockchain-beyond-bitcoin-tech-giants-to-gain?cid=CS-ZC-FT-365533 Mar 27, 2019 - Technology giants IBM, Facebook (FB), SAP, Microsoft (MSFT) and Accenture (ACN) explore usages of blockchain in various industries, which is driving adoption.
Is a Beat in the Cards for Accenture (ACN) in Q2 Earnings? http://www.zacks.com/stock/news/364387/is-a-beat-in-the-cards-for-accenture-acn-in-q2-earnings?cid=CS-ZC-FT-364387 Mar 25, 2019 - Accenture's (ACN) second-quarter fiscal 2019 results likely to reflect strength across the majority of its segments and strong operating performance.
WEX Q4 Earnings and Revenue Surpass Estimates, Rise Y/Y http://www.zacks.com/stock/news/364195/wex-q4-earnings-and-revenue-surpass-estimates-rise-y-y?cid=CS-ZC-FT-364195 Mar 25, 2019 - WEX (WEX) fourth-quarter 2018 earnings and revenues improve on a year-over-year basis.
Is a Beat in Store for IHS Markit (INFO) in Q1 Earnings? http://www.zacks.com/stock/news/364095/is-a-beat-in-store-for-ihs-markit-info-in-q1-earnings?cid=CS-ZC-FT-364095 Mar 25, 2019 - IHS Markit's (INFO) first-quarter fiscal 2019 revenues and earnings are expected to improve year over year.
What's in the Offing for Franco-Nevada's (FNV) Q4 Earnings? http://www.zacks.com/stock/news/360754/whats-in-the-offing-for-franco-nevadas-fnv-q4-earnings?cid=CS-ZC-FT-360754 Mar 18, 2019 - Franco-Nevada (FNV) might not be set for an earnings beat in the fourth quarter despite solid performance of its Oil & Gas assets.
Will Accenture (ACN) Beat Estimates Again in Its Next Earnings Report? http://www.zacks.com/stock/news/359541/will-accenture-acn-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-359541 Mar 14, 2019 - Accenture (ACN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
III vs. ACN: Which Stock Should Value Investors Buy Now? http://www.zacks.com/stock/news/358628/iii-vs-acn-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-358628 Mar 11, 2019 - III vs. ACN: Which Stock Is the Better Value Option?
Accenture Introduces Intelligent Digital IAM Capability http://www.zacks.com/stock/news/358299/accenture-introduces-intelligent-digital-iam-capability?cid=CS-ZC-FT-358299 Mar 08, 2019 - The patent pending algorithm of the solution from Accenture (ACN) integrates with present IAM solutions to enhance access across an entire organization.
FDA accepts Foamix NDA for acne treatment FMX101; shares up 4% premarket https://seekingalpha.com/news/3440712-fda-accepts-foamix-nda-acne-treatment-fmx101-shares-4-percent-premarket?source=feed_news_all Mar 07, 2019 - Foamix Pharmaceuticals (NASDAQ:FOMX) is up 4% premarket on modest volume following the FDA's acceptance of its marketing application seeking approval for FMX101, a topical minocyline foam, for the tre

Pages: 1234567891011...34

<<<Page 6>